Aurelie Therier is an experienced professional in global regulatory affairs with a focus on oncology and rare diseases. Currently serving as the Head of Global Regulatory Affairs Oncology at Recordati Rare Diseases, Aurelie previously held a similar position at EUSA Pharma France. With a robust background at EUSA Pharma from 2015 to 2022, Aurelie has effectively led regulatory strategies for marketing authorizations and lifecycle management across diverse international markets. Prior roles included managerial and associate positions focusing on regulatory submissions and compliance for medicinal products and medical devices at various firms including Jazz Pharmaceuticals, Stago, and bioMérieux. Aurelie holds multiple master's degrees in health management and quality assurance, complemented by a foundational degree in biology.